AFLIBERCEPT VERSUS PLACEBO IN COMBINATION WITH DOCETAXEL AND PREDNISONE FOR TREATMENT OF MEN WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (VENICE): A PHASE 3, DOUBLE-BLIND RANDOMISED TRIAL ArticleTannock I.F., Fizazi K., Ivanov S., Thellenberg Karlsson, Flechon A., Skoneczna I., Orlandi F., Gravis G., Matveev V., Bavbek S., Gil T., Viana L., Aren O., Karyakin O., Elliott T., Birtle A., Magherini E., Hatteville L., Petrylak D., Tombal B. ...The Lancet Oncology. Vol. V14. 2013. P.. 760-768
A MULTINATION PHASE II TRIAL OF BEVACIZUMAB WITH LOW-DOSE INTERFERON-ALPHA2A AS FIRST-LINE TREATMENT OF METASTATIC RENAL CELL CARCINOMA: BEVLIN ArticleMelichar B., Bracarda S., Matveev V., Flekseev B., Ivanov S., Zyryanov A., Janciauskiene R., Fernebro E., Mulders P., Osborne S., Jethwa S., Mickisch G., Gore M., R.J.A. Van, Staehler M., Magne N., Bellmunt J.Annals of Oncology. Vol. V24. 2013.
